Zentalis Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2026 | 3.95 M | $19.15 M | 0.00% | 5.62% |
| BLACKROCK, INC. | 08/07/2026 | 3.75 M | $18.20 M | 195.59% | 5.34% |
| SQUADRON CAPITAL MANAGEMENT LLC | 08/14/2026 | 3.70 M | $17.95 M | 825.00% | 5.27% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 3.02 M | $14.67 M | 2.31% | 4.31% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.84 M | $13.75 M | 22.72% | 4.04% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 2.68 M | $13.00 M | -5.84% | 3.82% |
| CITADEL ADVISORS LLC | 09/02/2026 | 2.30 M | $11.15 M | 32.70% | 3.27% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 1.61 M | $7.80 M | -16.98% | 2.29% |
| OPALEYE MANAGEMENT INC. | 08/14/2026 | 1.41 M | $6.85 M | 0.00% | 2.01% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 1.39 M | $6.74 M | 100.00% | 1.98% |
| DECHENG CAPITAL LLC | 08/14/2026 | 1.32 M | $6.42 M | 0.00% | 1.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.28 M | $6.23 M | 106.77% | 1.83% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.11 M | $5.41 M | -1.56% | 1.59% |
| ISHARA INVESTMENTS LP | 08/14/2026 | 1.03 M | $4.97 M | -16.67% | 1.46% |
| PRIMECAP MANAGEMENT CO/CA/ | 08/14/2026 | 957.42 K | $4.64 M | 0.00% | 1.36% |
| PFIZER INC | 08/13/2026 | 953.83 K | $3.85 M | 0.00% | 1.36% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 950.00 K | $4.61 M | 100.00% | 1.35% |
| STATE STREET CORP | 08/07/2026 | 887.42 K | $4.30 M | 255.41% | 1.26% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 808.55 K | $3.92 M | 124.22% | 1.15% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 758.03 K | $3.68 M | -4.29% | 1.08% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 664.28 K | $3.22 M | -48.50% | 0.95% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 652.75 K | $3.17 M | 351.31% | 0.93% |
| MARSHALL WACE, LLP | 08/13/2026 | 591.47 K | $2.87 M | 50.64% | 0.84% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 574.81 K | $2.79 M | -9.78% | 0.82% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 546.57 K | $2.65 M | -63.17% | 0.78% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 542.85 K | $2.63 M | 99.55% | 0.77% |
| MORGAN STANLEY | 08/13/2026 | 471.25 K | $2.29 M | 34.56% | 0.67% |
| SQUADRON CAPITAL MANAGEMENT LLC | 08/14/2026 | 426.00 K | $2.07 M | 100.00% | 0.61% |
| NORTHERN TRUST CORP | 08/13/2026 | 388.30 K | $1.88 M | 228.55% | 0.55% |
| GSA CAPITAL PARTNERS LLP | 08/06/2026 | 374.26 K | $1.82 M | -39.68% | 0.53% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 372.56 K | $1.81 M | -19.48% | 0.53% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 336.94 K | $1.63 M | 10.66% | 0.48% |
| SEVEN FLEET CAPITAL MANAGEMENT LP | 08/17/2026 | 317.60 K | $1.45 M | 188.73% | 0.45% |
| FMR LLC | 08/13/2026 | 310.26 K | $1.50 M | 9.28% | 0.44% |
| UBS GROUP AG | 08/13/2026 | 297.38 K | $1.44 M | 90.99% | 0.42% |
| XTX TOPCO LTD | 08/14/2026 | 289.69 K | $1.41 M | -10.17% | 0.41% |
| CREATIVE PLANNING | 08/13/2026 | 285.00 K | $1.38 M | 0.00% | 0.41% |
| SEI INVESTMENTS CO | 08/14/2026 | 256.08 K | $1.24 M | 33.69% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 215.11 K | $1.04 M | -62.34% | 0.31% |
| PEAPOD LANE CAPITAL LLC | 07/27/2026 | 202.86 K | $983.89 K | -44.70% | 0.29% |
| CDC FINANCIAL, INC. | 08/14/2026 | 177.76 K | $862.15 K | -37.36% | 0.25% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 171.91 K | $833.77 K | 236.51% | 0.24% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 171.91 K | $833.77 K | 100.00% | 0.24% |
| INVESCO LTD. | 08/14/2026 | 161.66 K | $784.04 K | 28.54% | 0.23% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/17/2026 | 161.58 K | $783.68 K | -39.95% | 0.23% |
| BARCLAYS PLC | 08/14/2026 | 158.86 K | $770.45 K | -73.13% | 0.23% |
| EAM INVESTORS, LLC | 08/13/2026 | 126.86 K | $615.29 K | 100.00% | 0.18% |
| QUARRY LP | 08/14/2026 | 125.11 K | $606.80 K | -16.59% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 122.07 K | $592.03 K | 100.00% | 0.17% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2026 | 112.12 K | $543.79 K | 100.00% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Zentalis Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 161 institutional investors and hedge funds held shares of Zentalis Pharmaceuticals Inc. The most heavily invested institutionals were:
5AM Venture Management, LLC: 3.95 M
BlackRock, Inc.: 3.75 M
Squadron Capital Management LLC: 3.7 M
TWO SIGMA INVESTMENTS, LP: 3.02 M
VANGUARD CAPITAL MANAGEMENT LLC: 2.84 M
ACADIAN ASSET MANAGEMENT LLC: 2.68 M
67.68% of Zentalis Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 61.85 M shares in the last 24 months. This purchase volume represents approximately $153.39 M in transactions.